Bacterial growth dynamics and pharmacokinetic–pharmacodynamic relationships of rifampicin and bedaquiline in BALB/c mice
Author:
Affiliation:
1. Clinical Pharmacology & Therapeutics Group, School of Life and Medical Sciences University College London London UK
2. Clinical Pharmacology, Modelling and Simulation GlaxoSmithKline Brentford UK
Funder
GlaxoSmithKline
UCLH Biomedical Research Centre
Publisher
Wiley
Subject
Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15688
Reference52 articles.
1. The concise guide to pharmacology 2019/20: Introduction and other protein targets;Alexander S. P. H.;British Journal of Pharmacology,2019
2. Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis
3. Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration
4. Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
5. Detecting Phenotypically Resistant Mycobacterium tuberculosis Using Wavelength Modulated Raman Spectroscopy
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. stormTB: A web-based simulator of a murine minimal-PBPK model for anti-tuberculosis treatments;2024-07-08
2. A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial;Nature Medicine;2024-02-16
3. A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis;Frontiers in Pharmacology;2024-01-04
4. Model‐based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug‐resistant tuberculosis;British Journal of Clinical Pharmacology;2023-10-26
5. Prediction of lung exposure to anti-tubercular drugs using plasma pharmacokinetic data: Implications for dose selection;European Journal of Pharmaceutical Sciences;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3